Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Type I collagen vaginal gel is a topical therapeutic formulation designed to address female pelvic floor dysfunction (PFD) and related conditions. Type I collagen is the primary structural protein in the extracellular matrix of the vaginal wall and pelvic floor ligaments. In conditions like pelvic organ prolapse and stress urinary incontinence, there is often a degradation or deficiency of this collagen. The gel is intended to supplement or stimulate the restoration of the vaginal connective tissue, thereby improving structural integrity, elasticity, and moisture. It is being evaluated in clinical settings, such as by Shanghai 10th People's Hospital, for indications including mild-to-moderate pelvic organ prolapse, vaginal atrophy, and stress urinary incontinence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on type I collagen vaginal gel.